As President and CEO of Fresenius Kabi, Pierluigi Antonelli is at the forefront in helping create and lead the next step in our company’s strategic roadmap. During his distinguished career, he has held leading positions at numerous international corporations, including Novartis Oncology, Sandoz, Merck & Co, Bristol-Myers Squibb, McKinsey & Company and as CEO of Angelini Pharma. He holds an MBA from Kellogg School of Management and a degree in Business and Economics from L.U.I.S.S.
Speakers
